← Back to Clinical Trials
Recruiting NCT07357181

NCT07357181 Influence of Handedness on Upper Limb Recovery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07357181
Status Recruiting
Phase
Sponsor Centre Hospitalier Régional d'Orléans
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2026-06-02
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
evaluation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2026-06-02 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective, single-center observational study evaluates whether handedness is associated with upper-limb motor recovery after a recent unilateral stroke. Adults admitted to the stroke unit with a confirmed unilateral stroke within 5 days are included if they do not object to participation. Upper-limb impairment is assessed early after stroke and at 6 months using standardized clinical scales. Handedness is determined by self-report, and the Edinburgh Handedness Inventory is administered when feasible. The main hypothesis is that left-handed participants may show better upper-limb motor recovery at 6 months than right-handed participants, potentially due to differences in brain motor network lateralization.

Eligibility Criteria

Inclusion Criteria: 1. Confirmed unilateral recent stroke (less than 5 days). 2. Age 18 years and older. 3. Participant or proxy does not object to participation Exclusion Criteria: 1. Prior stroke with residual motor sequelae. 2. Pre-stroke upper-limb deficit. 3. Follow-up at 6 months not planned at Orléans. 4. Protected adult (guardianship/curatorship), person under legal protection, or deprived of liberty. 5. Pregnant or breastfeeding woman.

Contact & Investigator

Central Contact

Julien BONNAL, MK

✉ julien.bonnal@chu-orleans.fr

📞 00332 38 74 46 65

Frequently Asked Questions

Who can join the NCT07357181 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07357181 currently recruiting?

Yes, NCT07357181 is actively recruiting participants. Contact the research team at julien.bonnal@chu-orleans.fr for enrollment information.

Where is the NCT07357181 trial being conducted?

This trial is being conducted at Orléans, France.

Who is sponsoring the NCT07357181 clinical trial?

NCT07357181 is sponsored by Centre Hospitalier Régional d'Orléans. The trial plans to enroll 500 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology